Soluble Urokinase Plasminogen Activator Receptor Levels in Tuberculosis Patients at High Risk for Multidrug Resistance

Table 1

Characteristics of tuberculosis (TB) patients at high risk for multidrug resistance (MDR) and multidrug resistant TB.

Patient characteristic		MDR; (𝑛=10); 𝑛 (%)	NC; (𝑛=10); 𝑛 (%)	TF; (𝑛=10); 𝑛 (%)	𝑅; (𝑛=10); 𝑛 (%)	Total; (𝑛=40); 𝑛 (%)
BMI (kg/m^2)	<18	5 (50)	7 (70)	4 (40)	6 (60)	32 (80)
	18–22	3 (30)	3 (30)	4 (40)	4 (40)	18 (45)
	>22	2 (20)	0	2 (20)	0	4 (10)
Lesion width	Normal	0 (0)	0	1 (10)	0	1 (2.5)
	Minimal	0 (0)	1 (10)	1 (10)	1 (10)	3 (7.5)
	Moderate	0 (0)	2 (20)	3 (30)	3 (30)	9 (22.5)
	Far advanced	10 (100)	7 (70)	5 (50)	6 (60)	38 (95)
	Milier	0 (0)	0 (0)	0 (0)	0 (0)	3 (7.5)
ESR (mm/h)		65.1	63.5	24.6	62.1
Culture and DST	(+) MDR	10 (100)	2 (20)	1 (10)	2 (20)	15 (37.5)
	(+) nMDR	0 (0)	1 (10)	4 (40)	5 (50)	10 (40)
	Culture (−)	0 (0)	7 (70)	4 (40)	2 (20)	13 (52.5)
	MOTT	0 (0)	0 (0)	1 (10)	1 (10)	2 (5)

BMI: Body mass index; DST: drug susceptibility test; eSR: erythrocyte sedimentation rate; MOTT: mycobacterium other than tuberculosis; NC: no conversion of AFB (+) into AFB (−) after two-month therapy; TF: therapy failure; 𝑅: relapse.